ADBiotech Co., Ltd. (KOSDAQ:179530)

South Korea flag South Korea · Delayed Price · Currency is KRW
2,955.00
+80.00 (2.78%)
At close: Dec 5, 2025
9.85%
Market Cap46.71B
Revenue (ttm)14.57B
Net Income (ttm)-11.02B
Shares Out16.36M
EPS (ttm)-1,029.38
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume122,086
Average Volume184,272
Open2,855.00
Previous Close2,875.00
Day's Range2,855.00 - 3,080.00
52-Week Range1,351.00 - 5,450.00
Beta1.41
RSI34.61
Earnings DateNov 13, 2025

About ADBiotech

ADBiotech Co., Ltd. develops and sells antibodies for livestock, fisheries, and humans in South Korea and internationally. The company offers antibiotic, disinfectant, helminthic, over the counter drugs, supplementary feed, and metabolic drugs. It also offers health functional and processed foods. ADBiotech Co., Ltd. was founded in 2000 and is based in Chuncheon-si, South Korea. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2000
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 179530
Full Company Profile

Financial Performance

In 2024, ADBiotech's revenue was 11.14 billion, an increase of 6.34% compared to the previous year's 10.47 billion. Losses were -7.95 billion, 177.7% more than in 2023.

Financial Statements

News

There is no news available yet.